Sharing our perspective

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.


  • National Prescription Drug Take Back Day Slated for April 28

    by
    • Optum Workers' Comp
    | Apr 17, 2018
    Tag Icon
    Overdose, DEA
    Saturday, April 28, from 10 a.m. to 2 p.m., is National Prescription Drug Take Back Day sponsored by the U.S. Drug Enforcement Administration (DEA). The purpose of National Prescription Drug Take Back Day is to provide a safe, convenient, and responsible way to dispose of prescription medications that are unwanted, unused, or expired, while also educating the public on the potential abuse of medications.


  • New drug therapy approvals in 2017

    by
    • Optum Workers' Comp
    | Feb 01, 2018
    Tag Icon
    The U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) has published their annual report, Advancing Health through Innovation: New Drug Approvals and Other Drug Therapy Advances of 2017. This report not only summarizes the approval of 46 new medications in 2017, it also provides information on the CDER’s role in supporting the FDA’s efforts to endorse innovation, efficiently execute the review and approval of new medications while maintaining patient safety, and improve various treatments for patients


  • Primus announces recall of Limbrel®

    by
    • Optum Workers' Comp
    | Jan 31, 2018
    Tag Icon
    recall
    In an effort to cooperate with the U.S. Food and Drug Administration’s (FDA) request to recall Limbrel, Primus Pharmaceuticals announced it is now voluntarily recalling all unexpired lots of this prescription medical food. Limbrel is used to manage the metabolic processes associated with osteoarthritis.


  • Recall of one lot of Senna Laxative 8.6 mg tablets

    by
    • Optum Workers' Comp
    | Jan 23, 2018
    Tag Icon
    recall, Laxatives
    Magno-Humphries Laboratories, Inc. announced a consumer-level recall of Basic Drugs Brand Senna Laxative (8.6 mg Sennosides) tablets. This recall is due to a complaint from a customer who found Naproxen Sodium 220 mg tablets in their bottle. At this time, no reports of injury or illness have been documented in relation to this issue.






Subscribe

Stay informed by signing up to receive newsletters, alerts, insights and videos.
You can customize your content preferences after you subscribe.